University of Toronto St. George Campus - Pharmacology
Associate VP & Vice-Provost, Strategic Initiatives at University of Toronto | Driving innovation & collaboration
Hospital & Health Care
Dr. Christine
Allen
Toronto, Ontario, Canada
Dr. Christine Allen is Associate Vice-President and Vice-Provost, Strategic Initiatives at the University of Toronto, driving innovation and collaboration across campus. She is an academic and business leader, entrepreneur and award-winning researcher and President Elect of the Canadian Society for Pharmaceutical Sciences (CSPS).
As co-founder and former president of Nanovista, a J&J Innovations JLabs company focused on developing an image-guided strategy to treat cancer, Dr. Allen led the founder group in a $2.3 million raise of seed capital. Nanovista was featured by Scientific American as one of 10 start-ups changing healthcare.
Prior to her current role, Dr. Allen was Interim Dean of the Leslie Dan Faculty of Pharmacy at the University of Toronto. She has held senior leadership roles in her Faculty, University of Toronto, external granting agencies and scientific societies. Dr. Allen’s research is focused on the development of advanced drug formulation and delivery strategies. She is an accomplished researcher with over 130 publications to her name,10% of which are featured in the Journal of Controlled Release (JCR), a top ranked journal in the pharmaceutical sciences field.
Follow Dr. Allen on Twitter @ChristineAllenW
President/Co-founder
Nanovista Inc. (nanovista.com) is a J&J Innovations JLabs company that was featured in Scientific American as one of 10 start-ups changing healthcare. In 2018, Dr. Allen led the founder group in a $2.3 million seed round of financing. These funds are being used for GMP manufacturing of a formulation and a Phase 1 clinical trial.
President Elect
The mission of Canadian Society for Pharmaceutical Sciences (CSPS) is to support a national network of pharmaceutical scientists in pursuit of excellence in pharmaceutical research, drug development and training. CSPS’ offerings include an annual conference, workshops and networking events.
Associate Vice-President & Vice-Provost, Strategic Initiatives
Dr. Allen works with other Vice-Presidential and Provostial portfolios to identify, assess, and support cross-divisional strategic initiatives involving research and other agencies and industry partners.
GSK Chair in Pharmaceutics and Drug Delivery
Christine worked at University of Toronto as a GSK Chair in Pharmaceutics and Drug Delivery
Interim Dean, Leslie Dan Faculty of Pharmacy
Christine worked at University of Toronto as a Interim Dean, Leslie Dan Faculty of Pharmacy
Full Professor
Dr. Allen leads a highly productive research program focused on the development of advanced drug formulations and delivery strategies. Her research has yielded over 130 publications with about 10% of her publications featured in the Journal of Controlled Release (JCR), a top ranked journal in the pharmaceutical sciences field. Dr. Allen is firmly committed to the commercialization and clinical translation of her research, as highlighted in examples provided below.
Associate Professor
Christine worked at University of Toronto as a Associate Professor
Chief Scientific Officer
Avicanna Inc. is a J&J Innovations JLabs company (https://avicanna.com) focused on research innovation in the cannabis space. Dr. Allen’s research with Avicanna has led to the formulation of a topical formulation containing cannabidiol for treatment of children with epidermolysis bullosa which is to be pursued in a Phase 1 trial at SickKids.
Associate Editor, Molecular Pharmaceutics
Christine worked at American Chemical Society as a Associate Editor, Molecular Pharmaceutics
Doctor of Philosophy - PhD
Chemistry
Bachelor of Science - BS
Biochemistry
Springer
Springer
PLOS One
The following profiles may or may not be the same professor: